LeBolt S A, Tisnado J, Cho S R
Department of Radiology, Medical College of Virginia, Richmond 23298-0615.
AJR Am J Roentgenol. 1988 Sep;151(3):589-92. doi: 10.2214/ajr.151.3.589.
A retrospective study of the efficacy of local low-dose intraarterial streptokinase for the treatment of peripheral arterial occlusion was performed in 60 cases. The results of treatment of occlusion of native arterial and arterial graft occlusions were compared. Twenty-two (73%) of 30 cases of arterial occlusion showed complete or partial angiographic resolution, compared with 16 (53%) of 30 cases of arterial graft occlusion. Ten (71%) of 14 patients with venous arterial grafts were successfully treated vs only six (38%) of 16 patients with prosthetic arterial grafts. These results suggest that streptokinase is an effective fibrinolytic agent for the treatment of arterial occlusion and arterial graft occlusion. Its effectiveness in arterial graft obstruction is comparatively low, although patients with venous grafts respond much more favorably than those with synthetic conduits.
对60例采用局部低剂量动脉内链激酶治疗外周动脉闭塞疗效的回顾性研究。比较了天然动脉闭塞和动脉移植物闭塞的治疗结果。30例动脉闭塞患者中有22例(73%)血管造影显示完全或部分再通,而30例动脉移植物闭塞患者中只有16例(53%)。14例采用静脉动脉移植物的患者中有10例(71%)成功治疗,而16例采用人工动脉移植物的患者中只有6例(38%)成功治疗。这些结果表明,链激酶是治疗动脉闭塞和动脉移植物闭塞的有效纤溶药物。其对动脉移植物阻塞的疗效相对较低,不过采用静脉移植物的患者比采用合成导管的患者反应要好得多。